Who Paid My Doc
Infugem
Drug Oncology
NDC 62756-219-60
General payments
$5,136
Research payments
$0
Through program year 2023, $5,136 in general payments and $0 in research payments were reported against Infugem (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $37 | 2 |
| 2022 | General | $139 | 5 |
| 2021 | General | $527 | 29 |
| 2020 | General | $2,860 | 161 |
| 2019 | General | $1,574 | 43 |
Breakdown
Each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2023 where a state was reported.
Records
240 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.